Antimicrobial peptides and wound healing: Biological and therapeutic considerations

Experimental Dermatology

Volumn 25, Issue 3, 2016, Pages 167-173

  Mangoni, Maria Luisa ^a   Mcdermott, Alison M ^b   Zasloff, Michael ^c  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF HOUSTON   (United States)

^c GEORGETOWN UNIVERSITY HOSPITAL   (United States)

Author keywords

Antibiotic resistance; Antimicrobial peptide; Frog skin; Innate immunity; Skin infections; Wound healing

Indexed keywords

ALPHA DEFENSIN; ALPHA DEFENSIN 5; ALPHA DEFENSIN 6; BETA DEFENSIN; BETA DEFENSIN 1; BETA DEFENSIN 2; BETA DEFENSIN 3; BETA DEFENSIN 4; CALGRANULIN; CATHELICIDIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CECROPIN A; CECROPIN B; DERMCIDIN; EPIDERMAL GROWTH FACTOR RECEPTOR; FORMYLPEPTIDE RECEPTOR LIKE 1; HISTONE H4; INTERLEUKIN 17; INTERLEUKIN 22; LUCIFENSIN; NISIN; PEXIGANAN; POLYPEPTIDE ANTIBIOTIC AGENT; PSORIASIN; RIBONUCLEASE; RIBONUCLEASE 5; RIBONUCLEASE 7; TEMPORIN A; TEMPORIN B; TYLOTOIN; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; ANTIMICROBIAL CATIONIC PEPTIDE;

AMINO ACID SEQUENCE; ANGIOGENESIS; ANTIMICROBIAL ACTIVITY; ARTICLE; ATOPIC DERMATITIS; CELL MIGRATION; CHEMOTAXIS; CORYNEBACTERIUM; CYTOKINE RELEASE; DEMODEX; EPITHELIUM CELL; ESCHERICHIA COLI; IMMUNE RESPONSE; INNATE IMMUNITY; KERATINOCYTE; MALASSEZIA; MOISTURE; NATURAL KILLER CELL; PROPIONIBACTERIUM; RESPIRATORY EPITHELIUM; SEBACEOUS CELL; SKIN CARE; SKIN INJURY; STAPHYLOCOCCUS; SWEAT GLAND; WOUND HEALING; ANIMAL; BACTERIAL INFECTION; CAENORHABDITIS ELEGANS; CYTOLOGY; DROSOPHILA MELANOGASTER; HUMAN; IMMUNE SYSTEM; IMMUNOLOGY; MICROFLORA; MOUSE; SKIN;

ANIMALS; ANTI-INFECTIVE AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIAL INFECTIONS; CAENORHABDITIS ELEGANS; CATHELICIDINS; DROSOPHILA MELANOGASTER; EPITHELIAL CELLS; HUMANS; IMMUNE SYSTEM; IMMUNITY, INNATE; MICE; MICROBIOTA; SKIN; WOUND HEALING;

EID: 84960077574     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/exd.12929     Document Type: Article

References (169)

1. Enyedi B, Niethammer P. Trends Cell Biol 2015: 25: 398-407.
2. Gallo R L, Hooper L V. Nat Rev Immunol 2012: 12: 503-516.
3. Kujath P, Kujath C. Eur J Med Res 2010: 15: 544-553.
4. Lau K, Paus R, Tiede S et al. Exp Dermatol 2009: 18: 921-933.
5. Hu M S, Maan Z N, Wu J C et al. Ann Biomed Eng 2014: 42: 1494-1507.
6. Ramot Y, Mastrofrancesco A, Camera E et al. Exp Dermatol 2015: 24: 245-251.
7. Mustoe T. Am J Surg 2004: 187: 65S-70S.
8. Demidova-Rice T N, Hamblin M R, Herman I M. Adv Skin Wound Care 2012: 25: 304-314.
9. Mancl K A, Kirsner R S, Ajdic D. Wound Repair Regen 2013: 21: 352-362.
10. Vyas K S, Wong L K. Ann Plast Surg 2015: 76: 127-131.
11. Wolcott R D, Rhoads D D, Bennett M E et al. J Wound Care 2010: 19: 45-46.
12. Breidenstein E B, de la Fuente-Nunez C, Hancock R E. Trends Microbiol 2011: 19: 419-426.
13. Mah T F, Pitts B, Pellock B et al. Nature 2003: 426: 306-310.
14. Taylor P K, Yeung A T, Hancock R E. J Biotechnol 2014: 191: 121-130.
15. Ovington L. Ostomy Wound Manage 2003: 49: 8-12.
16. Rajpaul K. Br J Community Nurs 2015: 20: S6.
17. Wilson M A. Am J Surg 2003: 186: 35S-41S.
18. Kish T D, Chang M H, Fung H B. Am J Geriatr Pharmacother 2010: 8: 485-513.
19. Hannigan G D, Pulos N, Grice E A et al. Adv Wound Care (New Rochelle) 2015: 4: 59-74.
20. Howell-Jones R S, Wilson M J, Hill K E et al. J Antimicrob Chemother 2005: 55: 143-149.
21. Lai Y, Gallo R L. Trends Immunol 2009: 30: 131-141.
22. Nakatsuji T, Gallo R L. J Invest Dermatol 2012: 132: 887-895.
23. Conlon J M. Peptides 2015: 67: 29-38.
24. Zasloff M. Nature 2002: 415: 389-395.
25. Steiner H, Hultmark D, Engstrom A et al. Nature 1981: 292: 246-248.
26. Ganz T, Selsted M E, Szklarek D et al. J Clin Invest 1985: 76: 1427-1435.
27. Zasloff M. Proc Natl Acad Sci USA 1987: 84: 5449-5453.
28. Wang G, Mishra B, Lau K et al. Pharmaceuticals (Basel) 2015: 8: 123-150.
29. Mangoni M L, Shai Y. Cell Mol Life Sci 2011: 68: 2267-2280.
30. Epand R M, Epand R F. Biochim Biophys Acta 2009: 1788: 289-294.
31. Wimley W C. ACS Chem Biol 2010: 5: 905-917.
32. Hale J D, Hancock R E. Expert Rev Anti Infect Ther 2007: 5: 951-959.
33. Fjell C D, Hiss J A, Hancock R E et al. Nat Rev Drug Discov 2012: 11: 37-51.
34. Nguyen L T, Haney E F, Vogel H J. Trends Biotechnol 2011: 29: 464-472.
35. Shai Y. Biopolymers 2002: 66: 236-248.
36. Rosenfeld Y, Papo N, Shai Y. J Biol Chem 2006: 281: 1636-1643.
37. Brandenburg K, Schromm A B, Gutsmann T. Subcell Biochem 2010: 53: 53-67.
38. Choi K Y, Chow L N, Mookherjee N. J Innate Immun 2012: 4: 361-370.
39. Narayana J L, Chen J Y. Peptides 2015: 72: 88-94.
40. Bhattacharjya S. Curr Top Med Chem 2016: 16: 4-15.
41. Yeung A T, Gellatly S L, Hancock R E. Cell Mol Life Sci 2011: 68: 2161-2176.
42. Fox J L. Nat Biotechnol 2013: 31: 379-382.
43. Mansour S C, Pena O M, Hancock R E. Trends Immunol 2014: 35: 443-450.
44. Cruz J, Ortiz C, Guzman F et al. Curr Med Chem 2014: 21: 2299-2321.
45. Dutta P, Das S. Curr Top Med Chem 2016: 16: 99-129.
46. Harder J, Schroder J M. J Biol Chem 2002: 277: 46779-46784.
47. Glaser R, Harder J, Lange H et al. Nat Immunol 2005: 6: 57-64.
48. Braff M H, Di Nardo A, Gallo R L. J Invest Dermatol 2005: 124: 394-400.
49. Yamasaki K, Gallo R L. Eur J Dermatol 2008: 18: 11-21.
50. Schroder J M. Curr Opin Infect Dis 2010: 23: 106-110.
51. Gallo R L. Exp Dermatol 2013: 22: 517.
52. Simanski M, Glaser R, Harder J. Exp Dermatol 2014: 23: 230-231.
53. Schroder J M, Harder J. Cell Mol Life Sci 2006: 63: 469-486.
54. Eckert R L, Broome A M, Ruse M et al. J Invest Dermatol 2004: 123: 23-33.
55. Nakashige T G, Zhang B, Krebs C et al. Nat Chem Biol 2015: 11: 765-771.
56. Abtin A, Eckhart L, Glaser R et al. J Invest Dermatol 2010: 130: 2423-2430.
57. Jensen J M, Ahrens K, Meingassner J et al. Exp Dermatol 2011: 20: 783-788.
58. Mallbris L, Carlen L, Wei T et al. Exp Dermatol 2010: 19: 442-449.
59. Lee D Y, Huang C M, Nakatsuji T et al. J Invest Dermatol 2009: 129: 2489-2496.
60. Rieg S, Garbe C, Sauer B et al. Br J Dermatol 2004: 151: 534-539.
61. Agerberth B, Charo J, Werr J et al. Blood 2000: 96: 3086-3093.
62. Grice E A, Segre J A. Nat Rev Microbiol 2011: 9: 244-253.
63. Grice E A, Kong H H, Conlan S et al. Science 2009: 324: 1190-1192.
64. Costello E K, Lauber C L, Hamady M et al. Science 2009: 326: 1694-1697.
65. Sanford J A, Gallo R L. Semin Immunol 2013: 25: 370-377.
66. Paulino L C, Tseng C H, Strober B E et al. J Clin Microbiol 2006: 44: 2933-2941.
67. Jarmuda S, O'Reilly N, Zaba R et al. J Med Microbiol 2012: 61: 1504-1510.
68. Harder J, Schroder J M, Glaser R. Exp Dermatol 2013: 22: 1-5.
69. Wanke I, Skabytska Y, Kraft B et al. Exp Dermatol 2013: 22: 153-155.
70. Percoco G, Merle C, Jaouen T et al. Exp Dermatol 2013: 22: 800-806.
71. Gallo R L, Nakatsuji T. J Invest Dermatol 2011: 131: 1974-1980.
72. Ong P Y, Ohtake T, Brandt C et al. N Engl J Med 2002: 347: 1151-1160.
73. Brogden N K, Mehalick L, Fischer C L et al. Skin Pharmacol Physiol 2012: 25: 167-181.
74. Steinz K, Schubert S, Harder J et al. Exp Dermatol 2014: 23: 862-864.
75. Elgarhy L H, Shareef M M, Moustafa S M. Clin Exp Dermatol 2015: 40: 361-366.
76. Steinstraesser L, Koehler T, Jacobsen F et al. Mol Med 2008: 14: 528-537.
77. Salzer S, Ruzicka T, Schauber J. Exp Dermatol 2014: 23: 379-381.
78. Morizane S, Gallo R L. J Dermatol 2012: 39: 225-230.
79. Harder J, Schroder J M. J Leukoc Biol 2005: 77: 476-486.
80. Schmidt N W, Jin F, Lande R et al. Nat Mater 2015: 14: 696-700.
81. Lande R, Gregorio J, Facchinetti V et al. Nature 2007: 449: 564-569.
82. Elloso M M, Gomez-Angelats M, Fourie A M. J Leukoc Biol 2012: 92: 1187-1197.
83. Roupe K M, Nybo M, Sjobring U et al. J Invest Dermatol 2010: 130: 1167-1177.
84. Niyonsaba F, Ushio H, Nakano N et al. J Invest Dermatol 2007: 127: 594-604.
85. Sorensen O E, Thapa D R, Rosenthal A et al. J Immunol 2005: 174: 4870-4879.
86. Niyonsaba F, Ushio H, Nagaoka I et al. J Immunol 2005: 175: 1776-1784.
87. Hirsch T, Spielmann M, Zuhaili B et al. J Gene Med 2009: 11: 220-228.
88. Semple F, Webb S, Li H N et al. Eur J Immunol 2010: 40: 1073-1078.
89. Semple F, MacPherson H, Webb S et al. Eur J Immunol 2011: 41: 3291-3300.
90. Jin G, Kawsar H I, Hirsch S A et al. PLoS ONE 2010: 5: e10993.
91. Tokumaru S, Sayama K, Shirakata Y et al. J Immunol 2005: 175: 4662-4668.
92. Heilborn J D, Nilsson M F, Kratz G et al. J Invest Dermatol 2003: 120: 379-389.
93. Koczulla R, von Degenfeld G, Kupatt C et al. J Clin Invest 2003: 111: 1665-1672.
94. Gallo R L, Ono M, Povsic T et al. Proc Natl Acad Sci USA 1994: 91: 11035-11039.
95. Shalom-Feuerstain Ruby A D. Expert Rev Dermatol 2008: 3: 357-366.
96. Parfitt G J, Geyfman M, Xie Y et al. J Invest Dermatol 2015: 135: 1175-1177.
97. Kolar S S, McDermott A M. Cell Mol Life Sci 2011: 68: 2201-2213.
98. Di Meglio P, Perera G K, Nestle F O. Immunity 2011: 35: 857-869.
99. Otte J M, Werner I, Brand S et al. J Cell Biochem 2008: 104: 2286-2297.
100. Sheng Q, Lv Z, Cai W et al. Pediatr Res 2014: 76: 269-279.
101. Shaykhiev R, Beisswenger C, Kandler K et al. Am J Physiol Lung Cell Mol Physiol 2005: 289: L842-L848.
102. Chisholm A D. Adv Wound Care (New Rochelle) 2015: 4: 264-271.
103. Onfelt Tingvall T, Roos E, Engstrom Y. EMBO Rep 2001: 2: 239-243.
104. Anderson A E, Galko M J. Exp Dermatol 2014: 23: 809-810.
105. Zugasti O, Ewbank J J. Nat Immunol 2009: 10: 249-256.
106. Alibardi L. Adv Anat Embryol Cell Biol 2010: 207: 1-109.
107. Raghavan K V, Babu M, Rajaram R et al. Lipids Health Dis 2010: 9: 74.
108. Campbell L J, Crews C M. Cell Mol Life Sci 2008: 65: 73-79.
109. Satoh A, Graham G M, Bryant S V et al. Dev Biol 2008: 319: 321-335.
110. Mu L, Tang J, Liu H et al. FASEB J 2014: 28: 3919-3929.
111. Otvos L Jr, Ostorhazi E. Expert Rev Anti Infect Ther 2015: 13: 871-881.
112. Mashreghi M, Rezazade Bazaz M, Mahdavi Shahri N et al. J Ethnopharmacol 2013: 145: 793-797.
113. Meier N T, Haslam I S, Pattwell D M et al. PLoS ONE 2013: 8: e73596.
114. Liu H, Mu L, Tang J et al. Int J Biochem Cell Biol 2014: 49: 32-41.
115. Simonetti O, Cirioni O, Goteri G et al. Peptides 2008: 29: 520-528.
116. Rezazade Bazaz M, Mashreghi M, Mahdavi Shahri N et al. Pharm Biol 2013: 51: 1600-1606.
117. Di Grazia A, Luca V, Segev-Zarko L A et al. Antimicrob Agents Chemother 2014: 58: 2520-2527.
118. Liu H, Duan Z, Tang J et al. FEBS J 2014: 281: 4633-4643.
119. Islas-Rodriguez A E, Marcellini L, Orioni B et al. J Pept Sci 2009: 15: 607-614.
120. Conlon J M. Peptides 2008: 29: 1815-1819.
121. Luca V, Stringaro A, Colone M et al. Cell Mol Life Sci 2013: 70: 2773-2786.
122. Di Grazia A, Cappiello F, Imanishi A et al. PLoS ONE 2015: 10: e0128663.
123. Ge Y, MacDonald D, Henry M M et al. Diagn Microbiol Infect Dis 1999: 35: 45-53.
124. Ge Y, MacDonald D L, Holroyd K J et al. Antimicrob Agents Chemother 1999: 43: 782-788.
125. Foster D, Lauver L S. Ostomy Wound Manage 2014: 60: 16-22.
126. Lipsky B A, Berendt A R, Deery H G et al. Clin Infect Dis 2004: 39: 885-910.
127. Ge Y, MacDonald D, Hait H et al. Diabet Med 2002: 19: 1032-1034.
128. Lipsky B A, Holroyd K J, Zasloff M. Clin Infect Dis 2008: 47: 1537-1545.
129. Gronberg A, Mahlapuu M, Stahle M et al. Wound Repair Regen 2014: 22: 613-621.
130. Chereddy K K, Her C H, Comune M et al. J Control Release 2014: 194: 138-147.
131. Do N, Weindl G, Grohmann L et al. Exp Dermatol 2014: 23: 326-331.
132. Shireen T, Singh M, Das T et al. Antimicrob Agents Chemother 2013: 57: 5134-5137.
133. Habets M G, Brockhurst M A. Biol Lett 2012: 8: 416-418.
134. Perron G G, Zasloff M, Bell G. Proc Biol Sci 2006: 273: 251-256.
135. Ali R S, Falconer A, Ikram M et al. J Invest Dermatol 2001: 117: 106-111.
136. Kesting M R, Stoeckelhuber M, Holzle F et al. Br J Dermatol 2010: 163: 121-127.
137. Dressel S, Harder J, Cordes J et al. Exp Dermatol 2010: 19: 628-632.
138. Yamasaki K, Di Nardo A, Bardan A et al. Nat Med 2007: 13: 975-980.
139. Nakatsuji T, Kao M C, Zhang L et al. J Invest Dermatol 2010: 130: 985-994.
140. Nagy I, Pivarcsi A, Kis K et al. Microbes Infect 2006: 8: 2195-2205.
141. Lee D Y, Yamasaki K, Rudsil J et al. J Invest Dermatol 2008: 128: 1863-1866.
142. Schittek B. J Innate Immun 2012: 4: 349-360.
143. Murakami M, Ohtake T, Dorschner R A et al. J Invest Dermatol 2002: 119: 1090-1095.
144. Narayanan S, Miller W L, McDermott A M. Invest Ophthalmol Vis Sci 2003: 44: 3795-3801.
145. McDermott A M. Ophthalmic Res 2009: 41: 60-75.
146. Garreis F, Schlorf T, Worlitzsch D et al. Histochem Cell Biol 2010: 134: 59-73.
147. McIntosh R S, Cade J E, Al-Abed M et al. Invest Ophthalmol Vis Sci 2005: 46: 1379-1385.
148. Haynes R J, Tighe P J, Dua H S. Lancet 1998: 352: 451-452.
149. Bals R, Hiemstra P S. Eur Respir J 2004: 23: 327-333.
150. Diamond G, Beckloff N, Ryan L K. J Dent Res 2008: 87: 915-927.
151. Singh P K, Jia H P, Wiles K et al. Proc Natl Acad Sci USA 1998: 95: 14961-14966.
152. Ganesan S, Comstock A T, Sajjan U S. Tissue Barriers 2013: 1: e24997.
153. Tecle T, Tripathi S, Hartshorn K L. Innate Immun 2010: 16: 151-159.
154. Bals R, Wang X, Zasloff M et al. Proc Natl Acad Sci U S A 1998: 95: 9541-9546.
155. Selsted M E, Ouellette A J. Nat Immunol 2005: 6: 551-557.
156. Bevins C L. Dig Dis 2013: 31: 299-304.
157. Kim J M. Intest Res 2014: 12: 20-33.
158. Ghiselli R, Giacometti A, Cirioni O et al. J Vasc Surg 2002: 36: 1027-1030.
159. Tang J, Liu H, Gao C et al. PLoS ONE 2014: 9: e92082.
160. Steinstraesser L, Hirsch T, Schulte M et al. PLoS ONE 2012: 7: e39373.
161. Heunis T D, Smith C, Dicks L M. Antimicrob Agents Chemother 2013: 57: 3928-3935.
162. Ostorhazi E, Holub M C, Rozgonyi F et al. Int J Antimicrob Agents 2011: 37: 480-484.
163. Ostorhazi E, Rozgonyi F, Sztodola A et al. J Antimicrob Chemother 2010: 65: 2416-2422.
164. Lee P H, Rudisill J A, Lin K H et al. Wound Repair Regen 2004: 12: 351-358.
165. Cerovsky V, Bem R. Pharmaceuticals (Basel) 2014: 7: 251-264.
166. Samy R P, Kandasamy M, Gopalakrishnakone P et al. PLoS ONE 2014: 9: e80199.
167. Tomioka H, Nakagami H, Tenma A et al. PLoS ONE 2014: 9: e92597.
168. Duplantier A, Jvan Hoek M L. Front Immunol 2013: 4: 143.
169. Ramos R, Silva J P, Rodrigues A C et al. Peptides 2011: 32: 1469-1476.